CGT
PFE icon

Capital Guardian Trust’s Pfizer PFE Stock Holding History

Capital Guardian Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4.2M Buy
102,113
+9,297
+10% +$369K 0.06% 154
2019
Q1 		$3.73M Sell
92,816
-39,873
-30% -$1.6M 0.05% 156
2018
Q4 		$5.5M Buy
132,689
+26,980
+26% +$1.12M 0.09% 142
2018
Q3 		$4.42M Buy
105,709
+13,581
+15% +$523K 0.06% 152
2018
Q2 		$3.17M Buy
92,128
+12,899
+16% +$441K 0.05% 158
2018
Q1 		$2.67M Buy
79,229
+13,897
+21% +$478K 0.04% 173
2017
Q4 		$2.25M Buy
65,332
+32,526
+99% +$1.11M 0.03% 176
2017
Q3 		$1.11M Sell
32,806
-155,032
-83% -$4.98M 0.02% 161
2017
Q2 		$5.99M Sell
187,838
-380,744
-67% -$12M 0.11% 135
2017
Q1 		$18.5M Sell
568,582
-123,614
-18% -$3.9M 0.14% 148
2016
Q4 		$21.3M Sell
692,196
-991,390
-59% -$30.3M 0.17% 131
2016
Q3 		$54.1M Buy
1,683,586
+57,466
+4% +$1.92M 0.41% 86
2016
Q2 		$54.3M Sell
1,626,120
-119,786
-7% -$3.82M 0.42% 89
2016
Q1 		$49.1M Buy
1,745,906
+70,019
+4% +$2M 0.38% 98
2015
Q4 		$51.3M Sell
1,675,887
-208,020
-11% -$6.54M 0.4% 89
2015
Q3 		$56.1M Sell
1,883,907
-2,867
-0.2% -$91.9K 0.45% 86
2015
Q2 		$60M Buy
1,886,774
+5,249
+0.3% +$171K 0.43% 86
2015
Q1 		$62.1M Buy
1,881,525
+1,121,306
+147% +$35.6M 0.46% 82
2014
Q4 		$22.5M Sell
760,219
-16,457
-2% -$472K 0.16% 132
2014
Q3 		$21.8M Buy
776,676
+67,287
+9% +$1.89M 0.16% 128
2014
Q2 		$20M Buy
709,389
+46,226
+7% +$1.32M 0.14% 133
2014
Q1 		$20.2M Buy
663,163
+14,039
+2% +$419K 0.14% 133
2013
Q4 		$18.9M Buy
649,124
+1,593
+0.2% +$46.4K 0.12% 132
2013
Q3 		$17.6M Sell
647,531
-88,401
-12% -$2.41M 0.12% 129
2013
Q2 		$19.6M Buy
+735,932
New +$20.3M 0.14% 127

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Guardian Trust's PFE Position: Q2 2019 in Review

Capital Guardian Trust increased its Pfizer (PFE) stake by 10% in Q2 2019, buying an estimated $369K and bringing the position to 102,113 shares worth $4.2M. The position accounts for 0.06% of the portfolio, ranked #154.

Capital Guardian Trust first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $62.1M in Q1 2015. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Capital Guardian Trust held 102,113 shares of Pfizer worth $4.2M as of Q2 2019.
  • Capital Guardian Trust bought 9,297 Pfizer shares in Q2 2019, an estimated $369K.
  • Pfizer made up 0.06% of Capital Guardian Trust's portfolio in Q2 2019, its #154 holding.
  • Capital Guardian Trust first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Capital Guardian Trust's Pfizer position peaked at $62.1M in Q1 2015.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.